Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
NCT06001125
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
27
Enrollment
OTHER
Sponsor class
Stopped
Challenges in meeting the enrollment target
Conditions
Arthritis
Arthralgia
Interventions
DRUG:
Methotrexate
Sponsor
AHS Cancer Control Alberta